glutathione and parkinsons parkinson treatment S-transferase: A keystone in Parkinson's disease pathogenesis therapy Glutathione S-transferase: A keystone in – Glutathione and Brain Health -

Immunosenescence contributes to: Increased infection risk Slower recovery from illness Reduced vaccine responsiveness Chronic inflammation Greater susceptibility to age-related diseases At the same time , many older adults experience "inflammaging," a state of persistent low-grade inflammation that accelerates biological aging

The role of dopamine in ADHD is also supported by the effectiveness of pharmacological interventions such as methylphenidate and amphetamines that increase dopamine levels in the synaptic cleft (Volkow, Wang et al., 2009)

200mg of highly bioavailable liposomal glutathione often provides more benefit than 1000mg of standard capsules that are mostly destroyed during digestion

Brown TD, Habibi N, Wu D, Lahann J, Mitragotri S

The complex pathophysiology and heterogeneity of the disease raises the speculation that combined treatment will be required for many patients

& Horemans, N